PolyPid Ltd.

General Information


We are a clinical-stage pharmaceutical company focused on developing and commercializing novel, locally administered therapies using our transformational PLEX (Polymer-Lipid Encapsulation matriX) technology. Our product candidates are designed to address unmet medical needs by pairing PLEX with active pharmaceutical ingredients, or APIs, which are delivered locally at predetermined release rates and durations over periods ranging from days to several months.

Employees: 55
Founded: 2008
Contact Information
Address 18 Hasivim Street, Petach Tikva 4959376, Israel
Phone Number +972 (74) 719-5700
Web Address http://www.polypid.com
View Prospectus: PolyPid Ltd.
Financial Information
Market Cap $29.5mil
Revenues $0 mil (last 12 months)
Net Income $-54.5 mil (last 12 months)
IPO Profile
Symbol POLY
Exchange NASDAQ
Shares (millions): 3.3
Price range $21.00 - $24.00
Est. $ Volume $75.0 mil
Manager / Joint Managers Goldman Sachs/ Cowen
CO-Managers Cantor/ Raymond James/ Oppenheimer
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change